Patrick J. Heron - 20 Jul 2021 Form 4 Insider Report for Imago BioSciences, Inc.

Role
Director
Signature
/s/ Patrick J. Heron
Issuer symbol
N/A
Transactions as of
20 Jul 2021
Net transactions value
+$3,000,000
Form type
4
Filing time
20 Jul 2021, 17:54:29 UTC
Previous filing
15 Jul 2021
Next filing
03 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMGO Common Stock Purchase $665,312 +41,582 $16.00 41,582 20 Jul 2021 See Footnote F1
transaction IMGO Common Stock Purchase $2,334,688 +145,918 $16.00 145,918 20 Jul 2021 See Footnote F2
transaction IMGO Common Stock Conversion of derivative security +341,932 +822% 383,514 20 Jul 2021 See Footnote F1, F3
transaction IMGO Common Stock Conversion of derivative security +211,069 +55% 594,583 20 Jul 2021 See Footnote F1, F3
transaction IMGO Common Stock Conversion of derivative security +64,360 +11% 658,943 20 Jul 2021 See Footnote F1, F3
transaction IMGO Common Stock Conversion of derivative security +1,199,890 +822% 1,345,808 20 Jul 2021 See Footnote F2, F3
transaction IMGO Common Stock Conversion of derivative security +740,673 +55% 2,086,481 20 Jul 2021 See Footnote F2, F3
transaction IMGO Common Stock Conversion of derivative security +225,850 +11% 2,312,331 20 Jul 2021 See Footnote F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMGO Series A Preferred Stock Conversion of derivative security $0 -341,932 -100% $0.000000* 0 20 Jul 2021 Common Stock 341,932 See Footnote F1, F3
transaction IMGO Series B Preferred Stock Conversion of derivative security $0 -211,069 -100% $0.000000* 0 20 Jul 2021 Common Stock 211,069 See Footnote F1, F3
transaction IMGO Series C Preferred Stock Conversion of derivative security $0 -64,360 -100% $0.000000* 0 20 Jul 2021 Common Stock 64,360 See Footnote F1, F3
transaction IMGO Series A Preferred Stock Conversion of derivative security $0 -1,199,890 -100% $0.000000* 0 20 Jul 2021 Common Stock 1,199,890 See Footnote F2, F3
transaction IMGO Series B Preferred Stock Conversion of derivative security $0 -740,673 -100% $0.000000* 0 20 Jul 2021 Common Stock 740,673 See Footnote F2, F3
transaction IMGO Series C Preferred Stock Conversion of derivative security $0 -225,850 -100% $0.000000* 0 20 Jul 2021 Common Stock 225,850 See Footnote F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares are held directly by Frazier Healthcare VII-A, L.P. ("FH VIIA"). The general partner of FH VIIA is FHM VII, L.P. and the general partner of FHM VII, L.P. is FHM VII, L.L.C., and each may be deemed to have sole voting, investment and dispositive power with respect to the shares held by FH VIIA. The Reporting Person is one of six members of FHM VII, L.L.C. The Reporting Person, FHM VII, L.P. and FHM VII, L.L.C. each disclaim Section 16 beneficial ownership of the securities held by FH VIIA, except to the extent of his or its pecuniary interest therein, if any.
F2 These shares are held directly by Frazier Healthcare VII, L.P. ("FH VII"). The general partner of FH VII is FHM VII, L.P. and the general partner of FHM VII, L.P. is FHM VII, L.L.C., and each may be deemed to have sole voting, investment and dispositive power with respect to the shares held by FH VII. The Reporting Person is one of six members of FHM VII, L.L.C. The Reporting Person, FHM VII, L.P. and FHM VII, L.L.C. each disclaim Section 16 beneficial ownership of the securities held by FH VII, except to the extent of his or its pecuniary interest therein, if any.
F3 Each share of the Issuer's Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering on July 20, 2021 and had no expiration date.